Biopharmaceutical manufacturer scaling production and supply chain across Africa and Middle East
Minapharm manufactures and commercializes over 100 pharmaceutical products across small molecules and complex proteins, with a gene-to-market bioprocess capability through its Berlin subsidiary. Active hiring across manufacturing and research (9 roles in 30 days) paired with concurrent ERP, supply-chain, and commercial digitalization projects signals a company scaling operations to meet demand volatility—a core pain point flagged across their planning and fulfillment functions.
Notable leadership hires: Microbiology Unit Head, Partnership Head
Minapharm Pharmaceuticals is a Cairo-headquartered manufacturer serving Egypt, the Middle East, and Africa with a portfolio spanning conventional drugs to immunotherapy biologics. Founded in 1958 and operating at 1,001–5,000 employees, the company owns a vertically integrated bioprocess capability through ProBioGen in Berlin, enabling internal development from genetic construct through commercial production. Current operations center on manufacturing optimization, analytical method improvement, and filling/filtration design, while organizational initiatives focus on supply-chain automation and commercial function digitalization.
Minapharm uses Oracle EBS and Oracle Process Manufacturing for operations; AutoCAD and Revit for process design; Python, LangGraph, and CrewAI for emerging automation; and Adobe Creative Suite (Photoshop, Illustrator, Premiere, InDesign) for commercial and marketing functions.
Active projects span purification and stability testing improvements, sterile filtration and filling design, ERP and supply-chain implementation, demand forecasting, and commercial digitalization. Core challenges center on demand-supply planning gaps, backorders, and supply-chain disruption mitigation.
Other companies in the same industry, closest in size